公司资料
Sanofi 股价、新闻与催化剂
- 股票代码:
- SNY
- 交易所:
- NASDAQ
- 行业:
- Generics, Antibody Drugs, CNS, Gene Therapy, Novel Therapies, Biopharma, Vaccines
- 所在地:
- France and listed in the U
股票表现
44.41 USD (+1.58%)
收盘价
最后更新: 2026年8月17日
102B USD
市值
股价为何变动
As of Aug 17, 2026, SNY closed up 1.58% at $44.41. No new same-company headline was identified in the current news window.
公司概览
业务概览
Sanofi is a global healthcare company with meaningful exposure to immunology, vaccines, rare disease, and consumer health. The company has been building a more focused innovation story while maintaining a broad global base.
所在地与行业分类
Headquartered in France and listed in the U.S. as an ADR, Sanofi operates globally across Europe, the U.S., and other major markets. It is one of the largest international biopharma names.
商业模式特征
Sanofi combines product revenue with pipeline investment and portfolio restructuring. Investors focus on immunology growth, vaccine performance, and the company’s ability to keep improving its innovation mix.
生物医药行业定位
Sanofi sits in the upper tier of global biopharma, where scale and pipeline quality matter more than single-stock binary events. It still reacts to major clinical and regulatory updates, especially in immunology and rare disease.
未来催化剂
- Sanofi should be watched for amlitelimab, tolebrutinib, and the broader immunology pipeline, where any positive progression would reinforce the company’s growth profile. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。